Cancer Metastatic

Oncology·MeSH: Neoplasm Metastasis

42 drugs in development·15 companies·2 clinical trials

Drug Pipeline by Phase

Phase 3(13)

Drug	Company
Abiraterone acetate	Merck & Co., Inc. (MRK)
acasunlimab	Genmab A/S (GMAB)
FOLFOX	KYNTRA BIO INC. (KYNB)
Hydrocortisone	Merck & Co., Inc. (MRK)
Hydrocortisone	Merus N.V. (MRUS)
IBI351, cetuximab β combined with FOLFIRI	IGM Biosciences, Inc. (IGMS)
Opevesostat	Merus N.V. (MRUS)
Osimertinib	Merus N.V. (MRUS)
Pemetrexed	ENANTA PHARMACEUTICALS INC (ENTA)
Physician's choice chemotherapy	ASTRAZENECA PLC (AZN)
Sintilimab injection	KYNTRA BIO INC. (KYNB)
Systemic therapy	IGM Biosciences, Inc. (IGMS)
Vinorelbine Tartrate	ENANTA PHARMACEUTICALS INC (ENTA)

Phase 2(18)

Drug	Company
amcenestrant	Sanofi (SNYNF)
amcenestrant	Sanofi (SNY)
Enhertu	KYNTRA BIO INC. (KYNB)
etrumadenant	Arcus Biosciences, Inc. (RCUS)
Etrumadenant	Arcus Biosciences, Inc. (RCUS)
FLOX	ENANTA PHARMACEUTICALS INC (ENTA)
FOLFIRI	Merus N.V. (MRUS)
Folfirinox	Merus N.V. (MRUS)
FOLFOX regimen	KYNTRA BIO INC. (KYNB)
MCLA-129	Merus N.V. (MRUS)
mFOLFIRINOX	Merus N.V. (MRUS)
mFOLFIRINOX	KYNTRA BIO INC. (KYNB)
mFOLFIRINOX infusion	Merus N.V. (MRUS)
mFOLFIRINOX Treatment Regimen	KYNTRA BIO INC. (KYNB)
Pemetrexed	Arcus Biosciences, Inc. (RCUS)
QL1706	Valneva SE (VALN)
tusamitamab ravtansine	Sanofi (SNY)
Vinorelbine	ENANTA PHARMACEUTICALS INC (ENTA)

Phase 1(3)

Drug	Company
Bavdegalutamide	ARVINAS, INC. (ARVN)
individualized anti-tumor new antigen iNeo-Vac-R01 injection	KYNTRA BIO INC. (KYNB)
sar408701	Sanofi (SNY)

Early Phase 1(1)

Drug	Company
experimental	VERTEX PHARMACEUTICALS INC / MA (VRTX)

Phase 1/Phase 2(6)

Drug	Company
ARV-110	ARVINAS, INC. (ARVN)
arv-766 + abiraterone part c&d	Novartis AG (NVS)
arv-766 part a&b	Novartis AG (NVS)
mfolfirinox treatment regimen	ONCOLYTICS BIOTECH INC (ONCY)
pelareorep	ONCOLYTICS BIOTECH INC (ONCY)
trifluridine tipiracil	ONCOLYTICS BIOTECH INC (ONCY)

Phase 4(1)

Drug	Company
Investigator's Choice of Chemotherapy	Merus N.V. (MRUS)

BioSniper tracks 42 drugs in development for Cancer Metastatic across 15 companies.

There are 2 clinical trials targeting Cancer Metastatic tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.